Butabarbital - PharmaKB

Butabarbital

Butabarb, Butalan, Buticaps, Butisol, Sarisol (butabarbital) is a small molecule pharmaceutical. Butabarbital was first approved as Butisol sodium on 1982-01-01. It is used to treat sleep initiation and maintenance disorders in the USA.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

Therapeutic Area	MeSH
nervous system diseases	D009422
mental disorders	D001523

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Butabarbital sodium

Tradename	Company	Number	Date	Products
BUTISOL SODIUM	Mylan	N-000793 DISCN	1982-01-01	4 products

Hide discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

Indication	Ontology	MeSH	ICD-10
sleep initiation and maintenance disorders	—	D007319	F51.01

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

No data

HCPCS

No data

Clinical

Clinical Trials

48 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Anesthesia	D000758	—	—	—	—	—	1	—	1
Intracranial vasospasm	D020301	EFO_1000994	G45.9	—	—	—	1	—	1
Kidney neoplasms	D007680	EFO_0003865	C64	—	—	—	1	—	1
Infections	D007239	EFO_0000544	—	—	—	—	1	—	1
Severe acute respiratory syndrome-related coronavirus	D045473	NCBITaxon_227859	—	—	—	—	1	—	1
Severe acute respiratory syndrome	D045169	EFO_0000694	J12.81	—	—	—	1	—	1
Myocarditis	D009205	—	I51.4	—	—	—	1	—	1
Renal dialysis	D006435	EFO_0010690	Z99.2	—	—	—	1	—	1
Virus diseases	D014777	—	B34	—	—	—	1	—	1

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Post-traumatic stress disorders	D013313	EFO_0001358	F43.1	—	—	1	—	—	1
Traumatic stress disorders	D040921	—	—	—	—	1	—	—	1
Gastroenteritis	D005759	EFO_1001463	K52.9	—	—	1	—	—	1

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Erectile dysfunction	D007172	EFO_0004234	F52.21	—	1	—	—	3	4
Prostatic neoplasms	D011471	—	C61	—	1	—	—	1	2

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Non-small-cell lung carcinoma	D002289	—	—	2	—	—	—	—	2
Lung neoplasms	D008175	—	C34.90	1	—	—	—	1	2
Vasculogenic impotence	D018783	EFO_1001234	—	1	—	—	—	—	1
Prostatic hyperplasia	D011470	EFO_0000284	N40	1	—	—	—	—	1
Hyperplasia	D006965	EFO_0000536	—	1	—	—	—	—	1
Schizophrenia	D012559	EFO_0000692	F20	1	—	—	—	—	1
Cognitive dysfunction	D060825	—	G31.84	1	—	—	—	—	1
Cognition disorders	D003072	—	—	1	—	—	—	—	1
Neurocognitive disorders	D019965	—	F09	1	—	—	—	—	1
Carcinoma	D002277	—	C80.0	1	—	—	—	—	1

Show 1 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Patellofemoral pain syndrome	D046788	EFO_1001092	—	—	—	—	—	6	6
Hip osteoarthritis	D015207	EFO_1000786	M16	—	—	—	—	5	5
Motor activity	D009043	EFO_0003940	—	—	—	—	—	3	3
Osteoarthritis	D010003	EFO_0002506	M15-M19	—	—	—	—	3	3
Knee osteoarthritis	D020370	EFO_0004616	M17	—	—	—	—	3	3
Oligospermia	D009845	—	N46.1	—	—	—	—	2	2
Peroneal neuropathies	D020427	EFO_1001102	G57.3	—	—	—	—	2	2
Spinal stenosis	D013130	EFO_0007490	M48.0	—	—	—	—	1	1
Penile neoplasms	D010412	—	C60	—	—	—	—	1	1
Joint diseases	D007592	—	M12.9	—	—	—	—	1	1

Show 27 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Butabarbital
INN	secbutabarbital
Description	Butabarbital is a member of barbiturates.
Classification	Small molecule
Drug class	barbituric acid derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	CCC(C)C1(CC)C(=O)NC(=O)NC1=O

Identifiers

PDB	—
CAS-ID	125-40-6
RxCUI	—
ChEMBL ID	CHEMBL449
ChEBI ID	3228
PubChem CID	2479
DrugBank	DB00237
UNII ID	P0078O25A9 (ChemIDplus, GSRS)

Target

No data

Variants

No data

Financial

Revenue by drug

€

₣

No data

Estimated US medical usage

Butabarbital

Total medical expenditures per year (USD, in millions)

Mock data
Subscribe for the real data

Number of persons purchased

Mock data
Subscribe for the real data

Number of purchases

Mock data
Subscribe for the real data

Refill frequency

Mock data
Subscribe for the real data

Price per prescription (USD)

Mock data
Subscribe for the real data

Butabarbital

Atropa belladonna

Total medical expenditures per year (USD, in millions)

Mock data
Subscribe for the real data

Number of persons purchased

Mock data
Subscribe for the real data

Number of purchases

Mock data
Subscribe for the real data

Refill frequency

Mock data
Subscribe for the real data

Price per prescription (USD)

Mock data
Subscribe for the real data

Butabarbital

Phenazopyridine

Hyoscyamine

Total medical expenditures per year (USD, in millions)

Mock data
Subscribe for the real data

Number of persons purchased

Mock data
Subscribe for the real data

Number of purchases

Mock data
Subscribe for the real data

Refill frequency

Mock data
Subscribe for the real data

Price per prescription (USD)

Mock data
Subscribe for the real data

Tabular view

Trends

PubMed Central

Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data

Additional graphs summarizing 168 documents

View more details

Safety

Black-box Warning

No Black-box warning

Adverse Events

Top Adverse Reactions

Mock data
Subscribe for the real data

43 adverse events reported

View more details